LabGenius, a frontrunner in the application of AI and machine learning for antibody discovery, has unveiled groundbreaking data from its antibody discovery platform, marking the culmination of a multi-year partnership with pharmaceutical giant Sanofi. The findings affirm the efficacy of LabGenius’ antibody discovery technology in co-optimizing the properties of monovalent NANOBODY® proteins while maintaining robust ... Read more
